EPC Stock Analysis: Edgewell Personal Care | NYSE
Household & Personal Products | NYSE, USA | Market Cap: 1.273m USD | 12M Return: 9.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.4M
EPS Trend: -46.6%
Qual. Beats: 1
Rev. Trend: -81.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Edgewell Personal Care Company (NYSE: EPC) is a U.S.-based manufacturer and marketer of personal care products sold worldwide, organized into three reportable segments: Wet Shave, Sun and Skin Care, and Feminine Care. Founded in 1772 and headquartered in Shelton, Connecticut, the company was formerly known as Energizer Holdings, Inc. before rebranding in June 2015. It distributes products through a combination of a direct sales force, exclusive and non-exclusive distributors, and wholesalers.
The Wet Shave segment is the companys largest historical business, offering razor systems, disposable razors, and shave preparation products under the Schick, Wilkinson Sword, Edge, Skintimate, Billie, and Skintimate brands, along with private label offerings. The Sun and Skin Care segment includes sun care products under the Banana Boat and Hawaiian Tropic brands, antibacterial wipes under Wet Ones, and mens grooming and skin care products under Bulldog, Jack Black, and Cremo. The Feminine Care segment markets tampons under the Playtex and o.b. brands, along with pads and liners under the Stayfree and Carefree labels.
As a small-cap stock in the Consumer Staples sector (GICS Sub-Industry: Personal Care Products), Edgewell operates in a category where brand equity, retail shelf placement, and consumer loyalty are central to the business model, and demand tends to be relatively stable through economic cycles. The company holds a portfolio of established heritage brands that compete against larger packaged goods companies, with its distribution model reaching both mass-market retailers and specialty channels globally.
- Wet Shave segment performance hinges on Schick and Billie brand momentum
- Sun Care revenue fluctuates with summer season and travel demand
- Private label competition and FX headwinds pressure margins
| Net Income: -77.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.53 > 1.0 |
| NWC/Revenue: 23.53% < 20% (prev 21.40%; Δ 2.13% < -1%) |
| CFO/TA 0.03 > 3% & CFO 117.3m > Net Income -77.8m |
| Net Debt (996.1m) to EBITDA (112.2m): 8.88 < 3 |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.5m) vs 12m ago -3.53% < -2% |
| Gross Margin: 41.00% > 18% (prev 42.60%; Δ -1.61% > 0.5%) |
| Asset Turnover: 57.67% > 50% (prev 58.96%; Δ -1.29% > 0%) |
| Interest Coverage Ratio: 0.37 > 6 (EBIT TTM 26.4m / Interest Expense TTM 71.4m) |
| A: 0.14 (Total Current Assets 1.11b - Total Current Liabilities 613.8m) / Total Assets 3.53b |
| B: 0.28 (Retained Earnings 995.8m / Total Assets 3.53b) |
| C: 0.01 (EBIT TTM 26.4m / Avg Total Assets 3.65b) |
| D: 0.69 (Book Value of Equity 1.45b / Total Liabilities 2.09b) |
| Altman-Z'' = 2.62 = A |
| DSRI: 1.20 (Receivables 267.7m/235.0m, Revenue 2.11b/2.22b) |
| GMI: 1.04 (GM 42.60% / 41.00%) |
| AQI: 0.94 (AQ_t 0.60 / AQ_t-1 0.64) |
| SGI: 0.95 (Revenue 2.11b / 2.22b) |
| TATA: -0.06 (NI -77.8m - CFO 117.3m) / TA 3.53b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of July 29, 2026, the stock is trading at USD 27.81 with a total of 387,483 shares traded. Over the past week, the price has changed by -2.73%, over one month by +0.11%, over three months by +21.32% and over the past year by +9.38%.
Current recommended Stop Loss: 26.00 (which is 6.5% or 1.4 ATR below the current price).
Edgewell Personal Care has received a consensus analysts rating of 3.78. Therefore, it is recommended to hold EPC.
- StrongBuy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 28 | 0.7% |
P/E Forward = 12.8866
P/S = 0.5699
P/B = 0.8792
P/EG = 2.8727
Revenue TTM = 2.11b USD
EBIT TTM = 26.4m USD
EBITDA TTM = 112.2m USD
Long Term Debt = 1.24b USD (from longTermDebt, last quarter)
Short Term Debt = 35.1m USD (from shortTermDebt, last quarter)
Debt = 1.30b USD (from shortLongTermDebtTotal, last quarter) + Leases 16.3m
Net Debt = 996.1m USD (calculated: Debt 1.30b - CCE 299.7m)
Enterprise Value = 2.27b USD (1.27b + Debt 1.30b - CCE 299.7m)
Interest Coverage Ratio = 0.37 (Ebit TTM 26.4m / Interest Expense TTM 71.4m)
EV/FCF = 46.69x (Enterprise Value 2.27b / FCF TTM 48.6m)
FCF Yield = 2.14% (FCF TTM 48.6m / Enterprise Value 2.27b)
FCF Margin = 2.31% (FCF TTM 48.6m / Revenue TTM 2.11b)
Net Margin = -3.69% (Net Income TTM -77.8m / Revenue TTM 2.11b)
Gross Margin = 41.00% ((Revenue TTM 2.11b - Cost of Revenue TTM 1.24b) / Revenue TTM)
Gross Margin QoQ = 43.43% (prev 38.08%)
Tobins Q-Ratio = 0.64 (Enterprise Value 2.27b / Total Assets 3.53b)
Interest Expense / Debt = 5.51% (Interest Expense 71.4m / Debt 1.30b)
Taxrate = 49.37% (3.90m / 7.90m)
NOPAT = 13.4m (EBIT 26.4m * (1 - 49.37%))
Current Ratio = 1.81 (Total Current Assets 1.11b / Total Current Liabilities 613.8m)
Debt / Equity = 0.89 (Debt 1.30b / totalStockholderEquity, last quarter 1.45b)
Debt / EBITDA = 8.88 (Net Debt 996.1m / EBITDA 112.2m)
Debt / FCF = 20.50 (Net Debt 996.1m / FCF TTM 48.6m)
Total Stockholder Equity = 1.51b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.13% (Net Income -77.8m / Total Assets 3.53b)
RoE = -5.14% (Net Income TTM -77.8m / Total Stockholder Equity 1.51b)
RoCE = 0.96% (EBIT 26.4m / Capital Employed (Equity 1.51b + L.T.Debt 1.24b))
RoIC = 0.47% (NOPAT 13.4m / Invested Capital 2.85b)
WACC = 4.72% (E(1.27b)/V(2.57b) * Re(6.68%) + D(1.30b)/V(2.57b) * Rd(5.51%) * (1-Tc(0.49)))
Discount Rate = 6.68% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.67 | Cagr: -3.60%
[DCF] Terminal Value 77.97% ; FCFF base≈42.0m ; Y1≈48.1m ; Y5≈70.8m
[DCF] Fair Price = 1.50 (EV 1.07b - Net Debt 996.1m = Equity 69.2m / Shares 46.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -46.59 | EPS CAGR: -5.93% | SUE: 1.37 | # QB: 1
Revenue Correlation: -81.64 | Revenue CAGR: -2.01% | SUE: 0.05 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.62 | Chg30d=-2.36% | Revisions=-67% | Analysts=7
EPS current Year (2026-09-30): EPS=1.89 | Chg30d=-0.21% | Revisions=+12% | GrowthEPS=-24.9% | GrowthRev=-10.2%
EPS next Year (2027-09-30): EPS=2.06 | Chg30d=+0.43% | Revisions=-62% | GrowthEPS=+9.1% | GrowthRev=+1.5%
[Analyst] Revisions Ratio: -53% (up=3, down=13)